Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults

Fleischman, Amy, Johnsen, Stine, Systrom, David M., Hrovat, Mirko, Farrar, Christian T., Frontera, Walter, Fitch, Kathleen, Thomas, Bijoy J., Torriani, Martin, Côté, Hélène C. F., Grinspoon, Steven K.·2007·American Journal of Physiology-Endocrinology and Metabolism
DOI 10.1152/ajpendo.00550.2006

Cited by (160)

Items 101–160 of 160

  1. In vivo assessment of mitochondrial toxicity
    Bradley F. Hamilton, Alan H. Stokes, Jonathan J. Lyon, Rick R. Adler · 2008 · Drug Discovery Today
  2. Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention
    Kathleen V. Fitch, Markella V. Zanni, Jennifer Manne‐Goehler, Marissa R Diggs, Arijeet K. Gattu, Judith S. Currier, Gerald S. Bloomfield, Chiu-Bin Hsiao, Samir Kumar Gupta, Judith A. Aberg et al. · 2024 · Annals of Internal Medicine
  3. Novel antibody-based strategies for the rapid diagnosis of mitochondrial disease and dysfunction
    Michael F. Marusich, James M. Murray, Jing Xie, Roderick Capaldi · 2009 · The International Journal of Biochemistry & Cell Biology
  4. Abdominal fat depots, insulin resistance, and incident diabetes mellitus in women with and without HIV infection
    Marshall Jay Glesby, David B. Hanna, Donald R. Hoover, Qiuhu Shi, Michael T. Yin, Phyllis C. Tien, Mardge H. Cohen, Kathryn Anastos, Anjali Sharma · 2018 · AIDS
  5. Histo-morphological and seminal evaluation of testicular parameters in diabetic rats under antiretroviral therapy: interactions with Hypoxis hemerocallidea.
    Ismail Olasile Onanuga, Ayoola Isaac Jegede, Ugochukwu Offor, Oluwatosin Olalekan Ogedengbe, Edwin Cs Naidu, Aniekan Imo Peter, Onyemaechi Okpara Azu · 2018 · Europe PMC (PubMed Central)
  6. Tenofovir alafenamide does not inhibit mitochondrial function and cholesterol biosynthesis in human T lymphoblastoid cell line
    Min Li, Lei Zhou, Harold Girum Dorsey, Charles Musoff, Dereck Dokyi Amakye, Natalie Schoen, Kweku Djan, Elijah Paintsil · 2020 · Antiviral Research
  7. Brief Report: Effects of Low-Volume High-Intensity Interval Training in Hispanic HIV+ Women: A Nonrandomized Study
    Farah A. Ramírez-Marrero, Sigrid Perez Frontera, Marcos A. Amalbert‐Birriel, Miriam Ríos Matos, Jorge L Santana-Bagur, Walter R. Frontera, Valerie Wojna · 2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  8. Mitochondrial Metabolism and Insulin Action
    Nigel A. Turner · 2013 · InTech eBooks
  9. Brief Report: Insulin Resistance Is Affected by Increased Levels of Plasma Lactate but not Mitochondrial Alterations in Skeletal Muscle in NRTI-Exposed HIV-Infected Patients
    Anne Maagaard, Mona Holberg‐Petersen, Peter Abusdal Torjesen, Johan N. Bruun, Dag Kvale · 2007 · HIV Clinical Trials
  10. Emerging roles of senolytics/senomorphics in HIV-related co-morbidities
    Gagandeep Kaur, Md. Sohanur Rahman, Sadiya Bi Shaikh, Kingshuk Panda, Srinivasan Chinnapaiyan, Maria Santiago Estevez, Li Xia, Hoshang Jehangir Unwalla, Irfan Rahman · 2024 · Biochemical Pharmacology
  11. HIV and cardiovascular risk
    Angela J. Robinson, Paul D. Benn, G Moyle, Paul Anthony Randell · 2008 · Clinical Medicine
  12. Lopimune-induced mitochondrial toxicity is attenuated by increased uncoupling protein-2 level in treated mouse hepatocytes
    Sara El Hoss, Georges M. Bahr, Karim S. Echtay · 2015 · Biochemical Journal
  13. Effects of antiretroviral combination therapies F/TAF, E/C/F/TAF and R/F/TAF on insulin resistance in healthy volunteers: The TAF-IR Study
    Christoph D. Spinner, Sebastian Schulz, Ulrike Bauer, Jochen Schneider, Johanna S. Bobardt, Alexander von Werder, Roland Michael Schmid, Alexander Zink, Eva Wolf, Roman Iakoubov · 2017 · Antiviral Therapy
  14. Insulin Resistance is Associated with Higher Plasma Viral Load Among HIV-Positive Adults Receiving Longer-Term (1 Year) Combination Antiretroviral Therapy (ART).
    Lloyd Mulenga, P. Musonda, Lameck Chirwa, Mpanji Siwingwa, Aggrey Mweemba, S Suwilanji, Sombo Fwoloshi, Henry Phiri, Daniel Chinyama Phiri, Patrick Mulenga et al. · 2019 · PubMed
  15. Absence of liver steatosis in HIV–HCV co-infected patients receiving regimens containing tenofovir or abacavir
    Vanni Borghi, Luca Bisi, Lisa Manzini, Andrea Cossarizza, Cristina Mussini · 2012 · Infection
  16. Type 2 Diabetes Mellitus in Tanzania. A Narrative Review of Epidemiology and Disease Trend
    Omary Chillo, Irene Charles Mzokolo, Elizabeth Gabriel Peter, EVANGELISTA KENAN MALINDISA, Hassan Thabit Haji, Alexander Mtemi Tungu, Marina Alois Njelekela, Emmanuel Balandya · 2024 · Current Diabetes Reviews
  17. Premature Onset of Cardiovascular Disease in HIV-Infected Individuals: The Drugs and the Virus
    Anna Maisa, Clare L V Westhorpe, Julian Elliott, Anthony Jaworowski, Anna C. Hearps, Anthony Michael Dart, Jennifer Hoy, Suzanne M. Crowe · 2010 · HIV Therapy
  18. Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV
    Richard E. Boehme, Stephen Cameron · 2009 · Antiviral Therapy
  19. Skeletal muscle mitochondrial DNA content and aerobic metabolism in patients with antiretroviral therapy-associated lipoatrophy
    Jussi Sutinen, Marko S. Laaksonen, Ulrich Andreas Walker, B. Setzer, Jukka Kemppainen, Pirjo Nuutila, Hannele Yki‐Järvinen · 2010 · Journal of Antimicrobial Chemotherapy
  20. Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2013)
    Panel de expertos de GeSIDA y Plan Nacional sobre el Sida · 2013 · Enfermedades Infecciosas y Microbiología Clínica
  21. Mitochondrial Toxicity of Antiviral Drugs: A Challenge to Accurate Diagnosis
    Michel P. de Baar, Anthony de Ronde · 2008 · Wiley eBooks
  22. Differential Subcutaneous Adipose Tissue Gene Expression Patterns in a Randomized Clinical Trial of Efavirenz or Lopinavir-Ritonavir in Antiretroviral-Naive Patients
    Lander Egaña-Gorroño, Estebán Martínez, Peré Domingo, Montserrat Loncà, Tuixent Escribà, Joan Fontdevila, Francesc Vidal, Eugènia Negredo, Josep M. Gatell, Mireia Arnedo · 2014 · Antimicrobial Agents and Chemotherapy
  23. Antiretroviral therapy and cardiovascular risk: are some medications cardioprotective?
    Benjamin J. Eckhardt, Marshall Jay Glesby · 2008 · Current Opinion in HIV and AIDS
  24. Dyslipidemia in HIV-Infected Patients
    Frederick J. Lee, Andrew D Carr · 2015 · Contemporary Endocrinology
  25. Cardiometabolic Risk, Inflammation, and Neurodegenerative Disorders
    Filipe Palavra, Ethel Ciampi, Armando Sena · 2015 · Springer eBooks
  26. Key reports from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 2007
    Ann Nestorowicz, Stephen Cameron · 2007 · Antiviral Therapy
  27. Endocrinology of HIV/AIDS
    Steven Kyle Grinspoon · 2016 · Elsevier eBooks
  28. HIV Infection and Diabetes
    Swaytha Yalamanchi, Todd Tarquin Brown, Adrian Sandra Dobs · 2016 · Springer eBooks
  29. The Role of Infections and Microbes in Atherosclerosis
    I. W. Fong · 2014 · Springer eBooks
  30. Increased skeletal muscle phosphocreatine recovery after sub-maximal exercise is associated with increased carotid intima–media thickness
    Hideo Makimura, Takara Leah Stanley, Noelle Sun, Jean M. Connelly, Linda Hemphill, Mirko I. Hrovat, David M. Systrom, Steven Kyle Grinspoon · 2010 · Atherosclerosis
  31. Diabetes, Prediabetes, and Metabolic Syndrome Among People Living with HIV
    Sowmya Chandra Reddy, William Bealle Moore, Papita Martina Rozario, Amy H. Warriner · 2019 · Springer eBooks
  32. Clevudine induced diabetes mellitus in a patient with chronic hepatitis B
    Gun Woo Kim, Mi Young Lee, Song‐Yi Kim, Jae Hyun Kim, Jin Hyung Lee, Choon Hee Chung · 2010 · The Korean Journal of Internal Medicine
  33. Enfermedad cardiovascular en el paciente infectado por el virus de la inmunodeficiencia humana
    María Larrousse, Estebán Martínez · 2010 · Hipertensión y Riesgo Vascular
  34. Cardiorespiratory Fitness Relative to Lean Body Mass in HIV+ and HIV− Women
    Farah A. Ramírez-Marrero, Valerie Wojna, Jorge L Santana-Bagur, Walter R. Frontera · 2019 · Journal of Clinical Exercise Physiology
  35. HIV Infection and Diabetes
    Madhu N. Rao, Kathleen M. Mulligan, Morris Schambelan · 2009 · Springer eBooks
  36. HIV-Infection: The Role of Insulin Resistance and Alternative Treatments
    Elaheh Aghdassi · 2011 · InTech eBooks
  37. Estudio del sistema musculoesquelético mediante resonancia magnética en la valoración del síndrome de lipodistrofia en pacientes infectados por el virus de la inmunodeficiencia humana
    García Díez, Ana Isabel · 2011 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  38. Les lipodystrophies et les troubles métaboliques associés à l’infection par le VIH et à son traitement : données actuelles
    Corinne Vigouroux, Martine Caron, Jean‐Philippe Bastard, Franck Boccara, Jacqueline Capeau · 2008 · Médecine des Maladies Métaboliques
  39. Lessons from HIV Lipodystrophy and Drug-Induced Metabolic Dysfunction
    Steven Kyle Grinspoon · 2010 · Springer eBooks
  40. How Sweet It Is? Susceptibility to Diabetes Mellitus in HIV-1 Treatment
    Katherine Samaras · 2009 · HIV Therapy
  41. HIV, insulin resistance and cardiovascular disease
    Katherine Samaras · 2008 · Current Cardiovascular Risk Reports
  42. Strategies to limit the metabolic complications of treatment for HIV infection
    Marit G. A. van Vonderen · 2009 · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
  43. Myocardial Infarction among HIV-infected patients enrolled in the North Carolina Medicaid program
    Emily Brouwer · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  44. The Impact of Tenofovir on Insulin Sensitivity and Lipids in Healthy Volunteers
    Paul Anthony Randell · 2008 · 46th Annual Meeting
  45. Lipodystrophies et troubles métaboliques associés à l'infection par le virus de l'immunodéficience humaine (VIH) et à ses traitements
    Corinne Vigouroux, Jacqueline Capeau · 2009 · EMC - Endocrinologie - Nutrition
  46. Comparing the glucose metabolism derangement in human immunodeficiency virus infection patients on antiretroviral treatment with drug nave patients at Lagos State University Teaching Hospital
    C. B. Basil, AO Dosunmu, Ibiyemi Ibitola Olatunji-Bello · 2016 · Journal of AIDS and HIV Research
  47. HIV Infection and Diabetes
    Swaytha Yalamanchi, Todd Tarquin Brown, Adrian Sandra Dobs · 2017 · Springer eBooks
  48. The Emerging Link between HIV Therapy and Diabetes
    Pratiksha Jadaun, Smita Kulkarni, Dhananjay Yadav, Priyanka Khopkar-Kale · 2016 · Journal of Bone Marrow Research
  49. UNIVERSIDADE FEDERAL DO CEARÁ FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM SAÚDE COLETIVA
    Clarisse Mourão Melo Ponte, Melo Ponte · 2010
  50. Glycemic Control in HIV Patients
    Geovani Palma, Lucia Gutiérrez-Spillari · 2017 · Current Tropical Medicine Reports
  51. Endocrinology of HIV/AIDS
    Steven Kyle Grinspoon · 2011 · Elsevier eBooks
  52. Antiviral drugs
    Oliver Koch, Susanne Helena Sheehy, Catherine Sargent, Jane Democratis, Sarah Abbas, Jurgen Schiefermueller, Brian Angus · 2010 · Side effects of drugs annual
  53. The prevalence of Type 2 Diabetes among people living with HIV in Georgia
    Tea Borkowska, Ekaterine Karkashadze, Nikoloz Chkhartishvili, Otar Chokoshvili, Tengiz Tsertsvadze · 2022 · GEORGIAN SCIENTISTS
  54. Le diabète au cours de l’infection par le VIH: a propos de 22cas
    Rania Rania, Et. Al · 2022 · Revue Malienne d Infectiologie et de Microbiologie
  55. Stavudine
    2015 · Elsevier eBooks
  56. Cardiovascular Disease, Metabolic Complications and Lipodystrophy in Persons with HIV
    Luis F. Pereira, Harold W. Goforth, Estebán Martínez, Joseph Z. Lux, Maria Ferrara, Michael P. Mullen · 2017
  57. I nuovi farmaci antidiabetici nelle persone che vivono con l’infezione da HIV.
    Marco Mirani · 2023 · JHA - Journal of HIV and Ageing
  58. Coronary artery disease and human immunodeficiency virus
    Tushar Sharma, Bhavina Sharma, Rahul Chaudhary, Nauder R. Faraday, Andrew Michael Goldsweig · 2025 · Current Problems in Cardiology
  59. Modulation pharmacologique et génétique de la fonctionnalité des particules HDL : Conséquences sur le risque cardiovasculaire et le développement de l'athérosclérose
    Petra El Khoury · 2014 · theses.fr (ABES)
  60. Cellular and biochemical effects induced by antiretroviral drugs.
    Khawar Anwar · 2013 · ResearchSpace (University of KwaZulu-Natal)